Nutra Pharma Corp. (NPHC)
OTCMKTS · Delayed Price · Currency is USD
0.0001
0.00 (0.00%)
Sep 4, 2026, 4:00 PM EST
Nutra Pharma Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 0.26 | 0.39 | 0.39 | 0.59 | 0.44 | 0.1 | |
Revenue Growth | -44.15% | -1.75% | -34.08% | 35.73% | 348.43% | 88.33% |
Cost of Revenue | 0.13 | 0.19 | 0.14 | 0.2 | 0.19 | 0.09 |
Gross Profit | 0.13 | 0.2 | 0.25 | 0.4 | 0.25 | 0.01 |
Selling, General & Admin | 1.71 | 1.61 | 1.13 | 1.18 | 2.08 | 1.93 |
Operating Expenses | 1.76 | 1.66 | 1.13 | 1.28 | 2.16 | 2 |
Operating Income | -1.64 | -1.46 | -0.88 | -0.89 | -1.91 | -1.99 |
Interest Expense | -0.45 | -0.44 | -0.32 | -0.4 | -0.79 | -0.5 |
Other Non Operating Income (Expenses) | -3.48 | -0.2 | -0.12 | -0.11 | 11.03 | -10.13 |
EBT Excluding Unusual Items | -5.57 | -2.11 | -1.32 | -1.4 | 8.33 | -12.61 |
Legal Settlements | 0.05 | 0.05 | - | - | - | - |
Other Unusual Items | 0.09 | 0.01 | 0.03 | 0.01 | -0.15 | -0.49 |
Pretax Income | -5.42 | -2.05 | -1.29 | -1.39 | 8.18 | -13.1 |
Net Income | -5.42 | -2.05 | -1.29 | -1.39 | 8.18 | -13.1 |
Net Income to Common | -5.42 | -2.05 | -1.29 | -1.39 | 8.18 | -13.1 |
Net Income Growth | - | - | - | - | - | - |
Shares Outstanding (Basic) | 7,943 | 7,779 | 7,674 | 7,608 | 7,503 | 7,233 |
Shares Outstanding (Diluted) | 7,943 | 7,779 | 7,674 | 7,608 | 19,097 | 7,233 |
Shares Change | 3.11% | 1.37% | 0.87% | -60.16% | 164.03% | 9.46% |
EPS (Basic) | -0.00 | -0.00 | -0.00 | -0.00 | 0.00 | -0.00 |
EPS (Diluted) | -0.00 | -0.00 | -0.00 | -0.00 | 0.00 | -0.00 |
EPS Growth | - | - | - | - | - | - |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | -1.05 | -1.19 | -0.42 | -0.55 | -0.82 | -1.78 |
Gross Margin | 48.54% | 51.03% | 63.07% | 66.64% | 56.82% | 8.66% |
Operating Margin | -632.16% | -379.52% | -224.00% | -149.10% | -435.21% | -2034.53% |
Profit Margin | -2093.61% | -531.37% | -327.85% | -234.22% | 1865.70% | -13399.01% |
Free Cash Flow Margin | -405.40% | -308.85% | -108.11% | -92.46% | -187.19% | -1824.84% |
EBITDA | -1.63 | -1.45 | -0.87 | -0.87 | -1.88 | -1.98 |
EBITDA Margin | - | - | -222.10% | -146.05% | - | - |
D&A For EBITDA | 0.01 | 0.01 | 0.01 | 0.02 | 0.02 | 0.01 |
EBIT | -1.64 | -1.46 | -0.88 | -0.89 | -1.91 | -1.99 |
EBIT Margin | - | - | -224.00% | -149.10% | - | - |